genetx biotherapeutics: gtx 102 phase 1/2 clinical trial update
Published 2 years ago • 686 plays • Length 19:24Download video MP4
Download video MP3
Similar videos
-
18:44
prof servais on the gtx-102 phase 1/2 clinical trial in the uk
-
16:31
genetx webinar
-
6:30
the use of gtx 102, an aso as a potential therapeutic for angelman syndrome dr scott stromatt 2020
-
14:51
genetx webinar
-
34:24
2019 fast summit on angelman syndrome - aso for potential treatment of as - genetx biotherapeutics
-
8:03
our daughter's rare diagnosis - angelman syndrome
-
46:52
ai based antibody therapeutics developability assessment and its engineering
-
9:19
a story about angelman syndrome
-
17:45
the use of gtx 102, an aso as a potential therapeutic for angelman syndrome dr berry-kravis
-
10:59
2023 ultragenyx update
-
24:46
rebecca crean | 2022 fast summit on angelman syndrome
-
42:41
tremendous hope that we will get to the finish line!
-
1:03:06
panel discussion with pharma
-
23:47
ultragenyx pharmaceutical inc.: overcoming challenges
-
1:29:21
pharma industry update session 2022 asf family conference
-
16:23
08- dr scott stromatt - genetx y ensayo clínico gtx-102
-
2:04
angelman syndrome clinical studies
-
51:08
2019 fast science summit on angelman syndrome - keynote, dr. emil kakkis, ultragenyx pharmaceutical